3rd Quarter - Report

UCB, INC. for UCB, INC.

Firm
Client
Income
—
Expenses
$340,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

HR 4993 - Joe Fiandra Access to Home Infusion Act

LobbyistCovered position, as disclosed
JED PERRY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 4993 (119th)

Trade (domestic/foreign) TRD

Sec. 232 Pharmaceutical Tariffs

LobbyistCovered position, as disclosed
JED PERRY —

Contacted: HOUSE OF REPRESENTATIVES; Intl Trade Administration (ITA); U.S. Trade Representative (USTR); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.